The Egyptian pharmaceutical company “Delta Pharma Bio” is ready to invest in the pharmaceutical industry of Tajikistan. This was stated by the general director of “Delta Pharma Bio” Mubarek Soleh at a meeting with the head of the Chamber of Commerce and Industry of Tajikistan, Sharif Said.
"The sides discussed promising areas of cooperation in the field of pharmaceuticals and public health, establishing a system of exchange of experience between Tajik and Egyptian specialists," the press service of the CCI RT reports.
According to Mubarek Soleh, his company is engaged in the production of medicines and other medical products.
“The company is ready to invest in the installation of a full cycle of production and technological lines of pharmaceutical enterprises in Tajikistan on the basis of modern technologies and equipment from Egypt in accordance with international standards” he said.
The Director General of “Delta Pharma Bio” noted that the company is aimed at supplying Egyptian medical technologies and medicines to the Tajik market.
"The company will produce preparations of various therapeutic groups, including for the treatment of hepatitis," he added.
